Tharimmune (THAR)
NASDAQ:THAR
US Market
Holding THAR?
Track your performance easily

Tharimmune (THAR) Stock News & Sentiment

63 Followers
Tharimmune Expands Immunology Pipeline with Intract License
Premium
Company Announcements
Tharimmune Expands Immunology Pipeline with Intract License
4d ago
Tharimmune ( ($THAR) ) has provided an announcement. Tharimmune, Inc. has secured an exclusive license from Intract Pharma to develop an oral version of the anti-inflammatory drug infliximab, expanding its ...Read more
Tharimmune’s Active Common Stock Shares Update
Premium
Company Announcements
Tharimmune’s Active Common Stock Shares Update
7M ago

News Score - Last 7 Days

Neutral
THAR
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average61%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is THAR’s Media Buzz Sentiment?
1 articles about THAR were published this week. In an average week, 1 articles are published.
    What is THAR’s weekly average amount of articles?
    In an average week, 1 articles about THAR are published.
      What is THAR’s News Sentiment?
      50% of articles about THAR were positive this week, compared to its sector average of 61%.
        Healthcare Stocks that are Trending in the News
        EPIXESSA Pharma
        ACRVAcrivon Therapeutics, Inc.
        IMCRImmunocore Holdings
        PSGPharmaSGP Holding SE
        NUVLNuvalent
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis